Analyst picks & changes

Biogen Inc.

(BGEN), Cambridge, Mass.

Business: Autoimmune/Inflammation

Hambrecht & Quist analyst Richard van den Broek said BGEN's loss of the Fiers patent in Europe has no impact on the company's ability to make and

Read the full 341 word article

How to gain access

Continue reading with a
two-week free trial.